S. Pereira

Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance

Z. Nwosu, N. Battello, W. Piorońska, 2020, EBioMedicine.

Application of patient‐derived liver cancer cells for phenotypic characterization and therapeutic target identification

S. Thorgeirsson, P. Galle, S. Heilmann-Heimbach, 2018, International journal of cancer.

Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes‐Associated Protein 1 Activation and Transient Expansion of Stem‐Like Cancer Cells

S. Thorgeirsson, P. Galle, S. Heilmann-Heimbach, 2021, Hepatology communications.

Application of patient derived liver cancer cell lines for phenotypic characterization and therapeutic target identification

S. Thorgeirsson, P. Galle, S. Heilmann-Heimbach, 2018, Zeitschrift für Gastroenterologie.